Novo Nordisk Licenses Vivtex Tech for Up to $2.1 Billion to Deepen Obesity Push
21 hours ago
5
The pharma elephantine struck a licensing woody to summation entree to transportation technologies developed by U.S. startup Vivtex., to deepen its pipeline of next-generation obesity drugs.